Caris MPI, Inc.

About Caris MPI, Inc.

Beyond Oncology With a primary focus on cancer, Caris has built a market-leading portfolio of precision medicine tools that have helped more than half a million cancer patients worldwide. Caris’ patient impact, as well as molecular knowledge of disease, has significantly vaulted the field of Oncology from an empiric medicine methodology to a precision medicine approach. Oncology is now widely recognized as one of the most genomically characterized fields in medicine and nearly every clinical trial for cancer includes a biomarker or molecular signature to evaluate drug performance. At Caris, we understand that cancer is an ugly word. A word you don’t want to hear. Yet, it’s a word that connects us all. At some point, in one way or another, disease will touch our lives. However, what connects us can also drive us and push us to do something about it. That’s why we introduced the idea of precision medicine to the world. An entire industry was born from our vision. A molecular science and AI powerhouse. Novel tools that fundamentally changed the way cancer is characterized and treated. Guided by an unwavering devotion to help patients – Always asking “What would I do if this patient was my mom?” Our relentless passion to unravel the complexities of molecular disease powers our progress. But we haven’t stopped at cancer. Driven by a decade of innovation to help build a better world. We are not waiting for change. We are the change, and it is happening now. We are pushing the boundaries of what is possible and leading a revolution in healthcare. With one common goal…. to improve the human condition across multiple diseases.